Skip to main content

Dimension Therapeutics Inc (NASDAQ:DMTX) Investor Investigation Concerning Possible Wrongdoing In Acquisition Announced

  • If you purchased shares of Dimension Therapeutics Inc (NASDAQ:DMTX) and currently hold any of those NASDAQ:DMTX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Dimension Therapeutics Inc (NASDAQ:DMTX), was announced concerning whether the takeover of Dimension Therapeutics Inc by REGENXBIO Inc for a value of approximately $3.41 per share is unfair to NASDAQ:DMTX stockholders. The investigation by a law firm concerns whether certain officers and directors of Dimension Thera...



You must register (for free) or login to view the entire investigation.